Consumer healthcare company Haleon has reportedgrowth across all its categories and regions in its third quarter amid healthy ...

Haleon’s household names such as Sensodyne and Paradontax toothpastes helped drive group revenue to £2.78bn. (Photo Illustration by Christof Koepsel/Getty Images) Consumer healthcare company ...

Shares in the Sensodyne and Voltaren maker were lower in early trading on Thursday as a result. Haleon told investors that revenues declined by 0.6% to £2.78 billion for the three months to ...

Shifting focus from self-medication to self-care’ Farhan Muhammad Haroon is the CEO & General Manager for Haleon in Pakistan ...

(Reuters) -Haleon posted an unexpected drop in third-quarter revenue on Thursday, hurt by a weak demand for its painkiller in ...

Revenues fall at Sensodyne maker Haleon after weaker painkiller sales - Shares were lower in early trading on Thursday as a ...

Haleon highlighted sharp growth in toothpaste and mouthwash brand Sensodyne, especially in India, the US, the UK and Germany, while parodontax, another toothpaste and mouthwash brand, grew double ...

It’s no surprise, then, that before Kinney takes on a fierce competition, she savors a soft, soothing morning. While she ...

Despite pressure on consumer spending, consumers prioritise trusted brands for their health-related needs and Haleon is a ...

Bank of America Securities analyst Victoria Petrova has maintained their bullish stance on HLN stock, giving a Buy rating on November 4.

Haleon missed third-quarter revenue and profit expectations on Thursday, hit by a stronger pound and lower sales of its ...